Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.04% | 16.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.04% | 16.44% | |||
| Cost of Revenue | 0.04% | 5.32% | |||
| Gross Profit | 0.04% | 18.79% | |||
| SG&A Expenses | 0.04% | 1.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 51.13% | |||
| Total Operating Expenses | 0.04% | 1.98% | |||
| Operating Income | 0.03% | 93.59% | |||
| Income Before Tax | 0.04% | 119.92% | |||
| Income Tax Expenses | 0.04% | 303.64% | |||
| Earnings from Continuing Operations | 0.03% | 113.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.03% | 113.91% | |||
| EBIT | 0.03% | 93.59% | |||
| EBITDA | 0.04% | 84.89% | |||
| EPS Basic | 0.00% | 133.33% | |||
| Normalized Basic EPS | 0.00% | 150.00% | |||
| EPS Diluted | 0.00% | 133.33% | |||
| Normalized Diluted EPS | 0.00% | 150.00% | |||
| Average Basic Shares Outstanding | 0.00% | -3.16% | |||
| Average Diluted Shares Outstanding | 0.00% | -3.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||